Diplomat Announces 4th Quarter and 2015 Year End Financial Results; Provides Initial 2016 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. DOX
4. VRTX
5. CHKP
6. CRWD
7. ON
8. INSP
9. HNGE
10. SPY

Go back to Diplomat Announces 4th Quarter and 2015 Year End Financial Results; Provides Initial 2016 Guidance

Leerink Partners Cuts Price target on Diplomat Pharmacy (DPLO) Following Weak EPS Guide

March 1, 2016 7:23 AM EST

Leerink Partners maintained an Outperform rating on Diplomat Pharmacy (NYSE: DPLO), and cut the price target to $35.00 (from $40.00), following the company's 4Q. DPLO reported revenue of $987M, ahead of consensus' $970M. Adjusted EPS of $0.21 beat the consensus of $0.20. 2016 guidance calls for total revenue of... More

Diplomat Pharmacy (DPLO) Tops Q4 EPS by 1c

February 29, 2016 4:16 PM EST

Diplomat Pharmacy (NYSE: DPLO) reported Q4 EPS of $0.21, $0.01 better than the analyst estimate of $0.20. Revenue for the quarter came in at $987 million versus the consensus estimate of $969.7 million.

GUIDANCE:

Diplomat Pharmacy sees FY2016 EPS of $0.84-$0.89, versus the consensus of... More